UroGen Pharma Balance Sheet Health
Financial Health criteria checks 2/6
UroGen Pharma has a total shareholder equity of $-65.2M and total debt of $98.6M, which brings its debt-to-equity ratio to -151.1%. Its total assets and total liabilities are $178.3M and $243.5M respectively.
Key information
-151.1%
Debt to equity ratio
US$98.55m
Debt
| Interest coverage ratio | n/a |
| Cash | US$136.97m |
| Equity | -US$65.21m |
| Total liabilities | US$243.52m |
| Total assets | US$178.31m |
Recent financial health updates
UroGen Pharma (NASDAQ:URGN) Is In A Good Position To Deliver On Growth Plans
Mar 09
We're Not Very Worried About UroGen Pharma's (NASDAQ:URGN) Cash Burn Rate
Nov 04Is UroGen Pharma (NASDAQ:URGN) In A Good Position To Invest In Growth?
Jun 14Recent updates
UroGen Pharma Ltd. (NASDAQ:URGN) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough
Apr 09UroGen: All Eyes On UGN-102
Mar 18UroGen Pharma Ltd. (NASDAQ:URGN) Just Released Its Annual Results And Analysts Are Updating Their Estimates
Mar 17UroGen Pharma Ltd. (NASDAQ:URGN) Looks Inexpensive But Perhaps Not Attractive Enough
Jan 18UroGen gets FDA nod for extending duration of Jelmyto admixture
Sep 28UroGen Pharma (NASDAQ:URGN) Is In A Good Position To Deliver On Growth Plans
Mar 09We're Not Very Worried About UroGen Pharma's (NASDAQ:URGN) Cash Burn Rate
Nov 04Is UroGen Pharma (NASDAQ:URGN) In A Good Position To Invest In Growth?
Jun 14What Does The Future Hold For UroGen Pharma Ltd. (NASDAQ:URGN)? These Analysts Have Been Cutting Their Estimates
May 18Financial Position Analysis
Short Term Liabilities: URGN has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: URGN has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: URGN has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: URGN's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: URGN has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: URGN has sufficient cash runway for 1.7 years if free cash flow continues to reduce at historical rates of 16% each year.